stop use immediately Recalls

Nipro Medical Hemodialysis System Recalled Due to Screw Hazard

Screw may loosen or fallout of Hemodialysis system

Medline Recalls Perfusion Syringe Due to Biocompatibility Issues

Medline Recalls Adhesive Bandages Due to Sterility Concerns

Medline recalled 4.4 million Quick Strip Plastic Sterile Adhesive Bandages on October 27, 2025. The recall affects all lots due to potential open seals compromising sterility. Consumers and healthcare providers should stop using these bandages immediately.

Medline Recalls Adhesive Bandages Over Sterility Concerns

Medline has identified that all lots of the Curad Touch-Free and Quick-Strip Bandages may exhibit open seals in the packaging which may compromise the sterility of the product.

Twin Sisters Creamery Whatcom Farmhouse Cheese Recalled for Potential Contamination (411 lbs, 2025)

EDAN Patient Monitors Recalled Over Cybersecurity Issues

EDAN recalled 3,824 Patient Monitors on October 24, 2025. The recall follows an FDA letter regarding cybersecurity vulnerabilities. Affected models include X8, X10, and X12, distributed nationwide and to Mexico.

EDAN Recalls Patient Monitors Due to Cybersecurity Risks

EDAN recalled 342 patient monitors on October 24, 2025, due to potential cybersecurity issues. Models affected include elite V5, elite V6, and elite V8. Healthcare providers and patients should stop using these devices immediately.

EDAN Patient Monitors Recalled Due to Cybersecurity Risks

EDAN recalled 379 patient monitors on October 24, 2025, due to potential cybersecurity issues. Models iX10, iX12, and iX15 pose risks to patient safety. Healthcare providers should stop using these devices immediately.

EDAN Recalls Patient Monitors Due to Cybersecurity Risks

As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.

EDAN Central Monitoring System Recalled Over Cybersecurity Issues

As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.

MeriCal Member's Mark Super Greens Recall 698,064 Units Over Salmonella Contamination (2025)

Potential contamination of Salmonella Richmond

EDAN Recalls Vital Signs Monitor Due to Cybersecurity Issues

As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.

EDAN Recalls Vital Signs Monitor Due to Cybersecurity Issues

As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.

EDAN Vital Signs Monitor Recalled Over Cybersecurity Issues

As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.

EDAN Recalls Vital Signs Monitors Due to Cybersecurity Risks

As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.

EDAN Vital Signs Monitor Recalled Over Cybersecurity Concerns

EDAN recalled 11,987 iM3 Vital Signs Monitors on October 24, 2025 due to potential cybersecurity risks. The recall affects devices distributed across the United States and Mexico.

EDAN Recalls Fetal & Maternal Monitors Over Cybersecurity Risks

EDAN recalled 3,518 fetal and maternal monitors on October 24, 2025, due to potential cybersecurity issues. Affected models include F6, F9, F6 Express, and F9 Express. The recall impacts devices distributed in the U.S. and Mexico.

EDAN Fetal Monitors Recalled Due to Cybersecurity Risk

As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.

EDAN Telemetry Transmitter Recalled Over Cybersecurity Concerns

As a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.

Cipla USA Recalls Lanthanum Carbonate Tablets Over Stability Issues

Cipla USA recalled 1,180 boxes of Lanthanum Carbonate chewable tablets on October 24, 2025. The recall follows a failure to meet stability specifications for hardness tests. Consumers and healthcare providers must stop using the product immediately.